CoChat
Sign Up
Cited by 238Dermatologic Treatments and ResearchGenetic and rare skin diseases.Dupuytren's Contracture and Treatments

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Genetics of keloid scarring

Shih, Barbara, Bayat, Ardeshir·2010·Archives of Dermatological Research
DOI 10.1007/s00403-009-1014-y
Open this paper in CoChat — free account

Abstract

Keloid scarring, also known as keloid disease (KD), is a common, abnormally raised fibroproliferative cutaneous lesion that can occur following even minor skin trauma. The aetiopathogenesis of KD has remained an enigma todate compounded by an ill-defined clinical management. There is strong evidence suggesting a genetic susceptibility in individuals affected by KD, including familial heritability, common occurrence in twins and high prevalence in certain ethnic populations. This review aims to address the genetic aspects of KD that have been described in present literature that include inheritance patterns, linkage studies, case-control association studies, whole genome gene expression microarray studies and gene pathways that were significant in KD. In addition to our clinical and scientific background in KD, we used search engines, Scopus, Scirus and PubMed, which searched for key terms covering various genetic aspects of KD. Additionally, genes reported in seven whole genome gene expression microarray studies were separately compared in detail. Our findings indicate a varied inheritance pattern in KD (predominantly autosomal dominant), linkage loci (chromosomes 2q23 and 7p11), several human leukocyte antigen (HLA) alleles (HLA-DRB1*15, HLA-DQA1*0104, DQ-B1*0501 and DQB1*0503), negative candidate gene case-control association studies and at least 25 dysregulated genes reported in multiple microarray studies. The major pathways reportedly proposed to be involved in KD include apoptosis, mitogen-activated protein kinase, transforming growth factor-beta, interleukin-6 and plasminogen activator inhibitor-1. In summary, involvement of more than one gene is likely to be responsible for susceptibility to KD. A better understanding of the genes involved in KD may potentially lead to the development of more effective diagnostic, therapeutic and prognostic measures.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00403-009-1014-y

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 153 references

Research works printed but not linked: 1

  1. Zhuo Y, Gao JH, Luo SQ, Zeng WS, Hu ZQ, Lu F, Zhao YZ (2005) p53 gene codon 72 polymorphism and susceptibility to keloid. Zhonghua Zheng Xing Wai Ke Za Zhi 21(3):201–203

Cited by

Sorted by citations

Items 101–200 of 238

Related

See all

Metadata

Authors
Shih, B., & Bayat, A.
Affiliations
University of Manchester (GB)
Corresponding author
Bayat, Ardeshir
ORCID
Venue
Archives of Dermatological Research
Publisher
Springer Science and Business Media LLC
Published
2010-02-04
Volume
302
Issue
5
Pages
319-339
ISSN
  • 0003-9187 (ISSN-L)
  • 0340-3696
  • 1432-069X
DOI
10.1007/s00403-009-1014-y
OpenAlex
W2025153976
Cited by
238
References
153
Citations by year
2026: 7 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 19 · 2021: 21 · 2020: 19 · 2019: 13 · 2018: 8 · 2017: 22 · 2016: 16 · 2015: 11 · 2014: 21 · 2013: 16 · 2012: 15
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Archives of Dermatological Research (publishedVersion)
  • PubMed (publishedVersion)
  • Lancaster EPrints (Lancaster University) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Health Sciences › Medicine › Dermatology › Genetic and rare skin diseases.
  • Health Sciences › Medicine › Rheumatology › Dupuytren's Contracture and Treatments
Keywords
keloids, genetic susceptibility, mode of inheritance, autosomal dominant inheritance, genetic linkage, HLA alleles, HLA-DRB1*15, gene expression microarrays, dysregulated genes, apoptosis, mitogen-activated protein kinase, TGF-beta, interleukin-6, plasminogen activator inhibitor-1, ethnic predisposition
MeSH terms
Cicatrix, Clinical Trials as Topic, HLA Antigens, Humans, Keloid, Polymorphism, Genetic, Transforming Growth Factor beta, Apoptosis, Plasminogen Activator Inhibitor 1, Genetic Predisposition to Disease, Oligonucleotide Array Sequence Analysis, Mitogen-Activated Protein Kinases, Inheritance Patterns, Genome-Wide Association Study

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review